Medpace (MEDP) PT Lowered to $400 at BMO Capital

April 24, 2026 9:27 AM

BMO Capital analyst Sean Dodge lowered the price target on Medpace (NASDAQ: MEDP) to $400.00 (from $460.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found